These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 8187332)

  • 21. Immunity to onchocerciasis: cells from putatively immune individuals produce enhanced levels of interleukin-5, gamma interferon, and granulocyte-macrophage colony-stimulating factor in response to Onchocerca volvulus larval and male worm antigens.
    Turaga PS; Tierney TJ; Bennett KE; McCarthy MC; Simonek SC; Enyong PA; Moukatte DW; Lustigman S
    Infect Immun; 2000 Apr; 68(4):1905-11. PubMed ID: 10722581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemokines in onchocerciasis patients after a single dose of ivermectin.
    Fendt J; Hamm DM; Banla M; Schulz-Key H; Wolf H; Helling-Giese G; Heuschkel C; Soboslay PT
    Clin Exp Immunol; 2005 Nov; 142(2):318-26. PubMed ID: 16232219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antigenicity and specificity of very low molecular weight Onchocerca volvulus polypeptides in the range 2.2-12.5 kD.
    Hoffmann WH; Blanke CH; Maier JM; Lüder CG; Schulz-Key H; Soboslay PT
    Trop Med Int Health; 1997 Jul; 2(7):635-45. PubMed ID: 9270732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Onchocerca volvulus-mediated keratitis: cytokine production by IL-4-deficient mice.
    Pearlman E; Lass JH; Bardenstein DS; Diaconu E; Hazlett FE; Albright J; Higgins AW; Kazura JW
    Exp Parasitol; 1996 Nov; 84(2):274-81. PubMed ID: 8932777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunity to onchocerciasis: putative immune persons produce a Th1-like response to Onchocerca volvulus.
    Elson LH; Calvopiña M; Paredes W; Araujo E; Bradley JE; Guderian RH; Nutman TB
    J Infect Dis; 1995 Mar; 171(3):652-8. PubMed ID: 7876612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of human immune responses to the cytosolic superoxide dismutase and glutathione S-transferase from Onchocerca volvulus.
    Brattig NW; Henkle-Dührsen KH; Hounkpatin S; Liebau E; Kruppa TF; Zipfel PF
    Trop Med Int Health; 1997 Aug; 2(8):788-98. PubMed ID: 9294549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T cell responses in coinfection with Onchocerca volvulus and the human immunodeficiency virus type 1.
    Sentongo E; Rubaale T; Büttner DW; Brattig NW
    Parasite Immunol; 1998 Sep; 20(9):431-9. PubMed ID: 9767610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Onchocerciasis modulates the immune response to mycobacterial antigens.
    Stewart GR; Boussinesq M; Coulson T; Elson L; Nutman T; Bradley JE
    Clin Exp Immunol; 1999 Sep; 117(3):517-23. PubMed ID: 10469056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Onchocerca volvulus: a comparative study of in vitro neutrophil killing of microfilariae and humoral responses in infected and endemic normals.
    Johnson EH; Lustigman S; Kass PH; Irvine M; Browne J; Prince AM
    Exp Parasitol; 1995 Aug; 81(1):9-19. PubMed ID: 7628571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transient changes in cytokine profiles following ivermectin treatment of onchocerciasis.
    Steel C; Lujan-Trangay A; Gonzalez-Peralta C; Zea-Flores G; Nutman TB
    J Infect Dis; 1994 Oct; 170(4):962-70. PubMed ID: 7930742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reductions in microfilaridermia by repeated ivermectin treatment are associated with lower Plasmodium-specific Th17 immune responses in Onchocerca volvulus-infected individuals.
    Arndts K; Klarmann-Schulz U; Batsa L; Debrah AY; Epp C; Fimmers R; Specht S; Layland LE; Hoerauf A
    Parasit Vectors; 2015 Mar; 8():184. PubMed ID: 25889652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigen-specific cellular hyporesponsiveness in a chronic human helminth infection is mediated by T(h)3/T(r)1-type cytokines IL-10 and transforming growth factor-beta but not by a T(h)1 to T(h)2 shift.
    Doetze A; Satoguina J; Burchard G; Rau T; Löliger C; Fleischer B; Hoerauf A
    Int Immunol; 2000 May; 12(5):623-30. PubMed ID: 10784608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoregulation in onchocerciasis: persons with ocular inflammatory disease produce a Th2-like response to Onchocerca volvulus antigen.
    Plier DA; Awadzi K; Freedman DO
    J Infect Dis; 1996 Aug; 174(2):380-6. PubMed ID: 8699070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired antibody responses and loss of reactivity to Onchocerca volvulus antigens by HIV-seropositive onchocerciasis patients.
    Tawill SA; Gallin M; Erttmann KD; Kipp W; Bamuhiiga J; Büttner DW
    Trans R Soc Trop Med Hyg; 1996; 90(1):85-9. PubMed ID: 8730320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemokines and cytokines in patients with an occult Onchocerca volvulus infection.
    Lechner CJ; Gantin RG; Seeger T; Sarnecka A; Portillo J; Schulz-Key H; Karabou PK; Helling-Giese G; Heuschkel C; Banla M; Soboslay PT
    Microbes Infect; 2012 May; 14(5):438-46. PubMed ID: 22202179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human onchocerciasis in Nigeria: isotypic responses and antigen recognition in individuals with defined cutaneous pathology.
    Murdoch ME; Abiose A; Garate T; Hay RJ; Jones BR; Maizels RM; Parkhouse RM
    Am J Trop Med Hyg; 1996 Jun; 54(6):600-12. PubMed ID: 8686779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early human infection with Onchocerca volvulus is associated with an enhanced parasite-specific cellular immune response.
    Cooper PJ; Mancero T; Espinel M; Sandoval C; Lovato R; Guderian RH; Nutman TB
    J Infect Dis; 2001 Jun; 183(11):1662-8. PubMed ID: 11343216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Production of both IFN-gamma and IL-5 by Onchocerca volvulus S1 antigen-specific CD4+ T cells from putatively immune individuals.
    Doetze A; Erttmann KD; Gallin MY; Fleischer B; Hoerauf A
    Int Immunol; 1997 May; 9(5):721-9. PubMed ID: 9184917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ov-ASP-1, the Onchocerca volvulus homologue of the activation associated secreted protein family is immunostimulatory and can induce protective anti-larval immunity.
    MacDonald AJ; Tawe W; Leon O; Cao L; Liu J; Oksov Y; Abraham D; Lustigman S
    Parasite Immunol; 2004 Jan; 26(1):53-62. PubMed ID: 15198646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune recognition of Onchocerca volvulus proteins in the human host and animal models of onchocerciasis.
    Manchang TK; Ajonina-Ekoti I; Ndjonka D; Eisenbarth A; Achukwi MD; Renz A; Brattig NW; Liebau E; Breloer M
    J Helminthol; 2015 May; 89(3):375-86. PubMed ID: 24721822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.